SCHEMBL7982641

SCHEMBL7982641

Cc1cc(C)c(S(=O)(=O)N[C@@](C)(CNC(=O)OC(C)(C)C)C(=O)O)c(C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 4/20 0.40
CA2 P00918 3/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
MMP8 P22894 1/20 0.40
MMP13 P45452 1/20 0.40
FABP4 P15090 1/20 0.40
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
MAPT P10636 2/20 0.36
TSHR P16473 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 1/20 0.36
EPHX2 P34913 1/20 0.36
F2 P00734 1/20 0.35
PRSS1 P07477 1/20 0.35
PRSS2 P07478 1/20 0.35
PRSS3 P35030 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trimethylammonium SCHEMBL7354979 0.82 FABP4 (0.36) CA1CA2MMP1MMP2MMP9
SCHEMBL4289710 0.76 CA1 (0.51) CA1CA2MMP1MMP2MMP9
SCHEMBL23846018 0.75 NFKB1 (0.41) CA1CA2MMP1MMP2MMP9
SCHEMBL7448661 0.75 ITGAV (0.59) ALDH1A1ITGAV
SCHEMBL7352639 0.74 MAPT (0.36) MAPTEPHX2RAB9A
SCHEMBL7354160 0.71 ITGAV (0.47) CA1CA2MMP1MMP2MMP9
SCHEMBL7354167 0.71 ITGAV (0.47) CA1CA2MMP1MMP2MMP9
SCHEMBL1618029 0.71 CA1 (0.46) CA1CA2NFKB1NFKB2RELA
SCHEMBL31636878 0.70 NFKB1 (0.40) CA1CA2MMP1MMP2MMP9
SCHEMBL17308770 0.70 FABP4 (0.49) CA1CA2MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6214834-B1 ANGIOGENESIS INHIBITORS; ANTIINFLAMMATORY AGENTS; ANTICANCER AGENTS DUPONT PHARMACEUTICALS COMPANY 2001-04-10 US disclosed